Migraine Headache Treated with Famciclovir and Celecoxib : A Case Report
INTRODUCTION: Herpes simplex virus (HSV) has been speculated to play a role in migraine headache pathophysiology. We present the first successful migraine headache treatment with therapy specifically targeting HSV infection.
CASE PRESENTATION: A previously healthy 21-year-old white woman presented with a severe headache and was diagnosed with severe migraine headache disorder. She initially was treated with standard migraine headache medications without symptomatic improvement. She was then given famciclovir and celecoxib. The patient fully recovered within days and continues to enjoy significant reduction in severity and frequency of symptoms.
DISCUSSION: Famciclovir and celecoxib may work synergistically against HSV. The virus may play a role in the pathophysiology of migraine headaches, and this is the first case report of successful migraine headache treatment with these medications. Further studies are needed to elucidate the efficacy of these medications in treating migraine disorder.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
The Permanente journal - 22(2018) vom: 13., Seite 17-020 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Napier, Bradford Lee [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
2-Aminopurine |
|---|
| Anmerkungen: |
Date Completed 24.07.2018 Date Revised 25.02.2019 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.7812/TPP/17-020 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM279013167 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM279013167 | ||
| 003 | DE-627 | ||
| 005 | 20231225022000.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.7812/TPP/17-020 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0930.xml |
| 035 | |a (DE-627)NLM279013167 | ||
| 035 | |a (NLM)29236660 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Napier, Bradford Lee |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Migraine Headache Treated with Famciclovir and Celecoxib |b A Case Report |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.07.2018 | ||
| 500 | |a Date Revised 25.02.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a INTRODUCTION: Herpes simplex virus (HSV) has been speculated to play a role in migraine headache pathophysiology. We present the first successful migraine headache treatment with therapy specifically targeting HSV infection | ||
| 520 | |a CASE PRESENTATION: A previously healthy 21-year-old white woman presented with a severe headache and was diagnosed with severe migraine headache disorder. She initially was treated with standard migraine headache medications without symptomatic improvement. She was then given famciclovir and celecoxib. The patient fully recovered within days and continues to enjoy significant reduction in severity and frequency of symptoms | ||
| 520 | |a DISCUSSION: Famciclovir and celecoxib may work synergistically against HSV. The virus may play a role in the pathophysiology of migraine headaches, and this is the first case report of successful migraine headache treatment with these medications. Further studies are needed to elucidate the efficacy of these medications in treating migraine disorder | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 650 | 7 | |a Cyclooxygenase 2 Inhibitors |2 NLM | |
| 650 | 7 | |a 2-Aminopurine |2 NLM | |
| 650 | 7 | |a 452-06-2 |2 NLM | |
| 650 | 7 | |a Celecoxib |2 NLM | |
| 650 | 7 | |a JCX84Q7J1L |2 NLM | |
| 650 | 7 | |a Famciclovir |2 NLM | |
| 650 | 7 | |a QIC03ANI02 |2 NLM | |
| 700 | 1 | |a Morimoto, Maki |e verfasserin |4 aut | |
| 700 | 1 | |a Napier, Erin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Permanente journal |d 1998 |g 22(2018) vom: 13., Seite 17-020 |w (DE-627)NLM097385794 |x 1552-5775 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2018 |g day:13 |g pages:17-020 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.7812/TPP/17-020 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2018 |b 13 |h 17-020 | ||